By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:


SEARCH JOBS




Collaborations

Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.





Company News
Solaranrx Signs Research Agreement With The NCI To Advance Metastatic Melanoma Theranostic 1/7/2016 11:22:24 AM
BeyondSpring Data Demonstrating Activity Of Plinabulin In Kras-Mutant Tumors Presented At AACR-NCI-EORTC International Conference 2015 11/17/2015 8:12:41 AM
Mechanistic Rationale For CYC065, Cyclacel Pharmaceuticals, Inc. (CYCC)l’s CDK2/9 Inhibitor, In Targeted Solid Tumors And Hematological Malignancies Presented At AACR-AACR-EORTC International Conference 11/9/2015 10:24:16 AM
Curis, Inc. (CRIS) Collaborator Aurigene Presents Preclinical Data From Oral Small Molecule PD-L1/VISTA And IRAK4 Programs At AACR-NCI-EORTC International Conference 11/9/2015 8:35:43 AM
Tesaro (TSRO) Announces Data Presentations For Niraparib At The 2015 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics 11/9/2015 8:10:12 AM
Sunesis (SNSS) Presents Preclinical Data From Its BTK And PDK1 Inhibitor Programs At The AACR-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics 11/9/2015 7:45:23 AM
NuCana Presents Exciting Data On Novel Anticancer Agent, NUC-3373, At The AACR-NCI-EORTC Conference In Boston 11/9/2015 7:38:06 AM
Guardant Health And Collaborators Present Further Clinical Utility Data For Guardant360 At The AACR-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics 11/9/2015 7:33:39 AM
CytomX Highlights Data From Multiple Probody Pipeline Programs At Investor Event During AACR-National Cancer Institute-EORTC Conference 11/9/2015 7:05:50 AM
CASI Pharmaceuticals  (CASI) Release: Data On Anti-Tumor Activity Of ENMD-2076 In Triple Negative Breast Cancer Animal Models Presented In Poster Session At AACR-National Cancer Institute-EORTC International Conference 11/9/2015 6:55:06 AM
12345678910...
//-->